InvestorsHub Logo
icon url

Mikefl

09/25/06 6:46 AM

#50915 RE: ann441j #50914

I'm sorry Ann but Dick Gabriel's "word" is meaningless when talking about shareholder value. Until management decides to get into the trenches with us (remove non-dilutive clauses) their comments about shareholder value are falling on these deaf ears.

I personally find it difficult to give Dick the benefit of the doubt when he has interests in both Biofrontera and DNAG. It just looks like he's got both hands in the both cookie jars, IMO.

And... I'm extremely uncomfortable with his statement of "we have established a reliable and trustworthy source of capital for the development of both companies". A realiable and trustworthy source that sells the heck out of the stock and has possibly/probably shorted it???

Sub-penny share price after the 1/20 reversal is shameful.
icon url

dr frudaky

09/25/06 7:38 AM

#50917 RE: ann441j #50914

ann441j


Yes, I am quite aware of all that...and so is every shareholder now wondering why all that glossy promise and greatness have now brought the pps to subpenny after the 1 for 20 first r/s. We are not heading for a possible subsubpenny pps and the second r/s.

IMO, the Biofrontera bruhaha has always been, IMO, just another "now you see it now you don't" management sleight of hand, not unlike the promised warrants deal after increasing the a/s to one billion, for putting more lipstick on this very ugly pig. Biofrontera is only a small company with very little money, a supposed skin ointment in development and a failed public offering of its stock which shocked the DNAG shareholders.

The bottom line is talk from the management of any company is cheap and meaningless. It is ONLY what the management does to back up that talk which counts. Unfortunately, DNAG management has done nothing over the past 6+ years except talk and destroy shareholder value.

JMHO for your kind consideration.

dr f
icon url

Sandoz

09/26/06 12:34 PM

#50931 RE: ann441j #50914

Ann, I like the way you think! With sound fundamentals coupled with consistent events/reports/strategies/partnerships DNAPrint is surely under valued. What are your specific thoughts/feelings on this company, rather than the news rhetoric?

Kind Regards,

Anders